Clinical Trials Directory

Trials / Completed

CompletedNCT00991341

Red Cell Storage Duration Study

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
1,481 (actual)
Sponsor
Carelon Research · Academic / Other
Sex
All
Age
12 Years
Healthy volunteers
Not accepted

Summary

The RECESS study will compare the effects of transfusing red blood cell units stored \<= 10 days vs. red blood cell units stored \>= 21 days, in patients who are undergoing complex cardiac surgery and are likely to need a red blood cell transfusion. The primary hypothesis is that there is a clinically important difference between the effects of shorter-storage red cell units and longer-storage red cell units on clinical outcomes and mortality risk.

Conditions

Interventions

TypeNameDescription
BIOLOGICALRed blood cell units stored <= 10 daysPre-storage leukoreduced red blood cell units stored \<=10 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.
BIOLOGICALRed blood cell units stored >= 21 daysPre-storage leukoreduced red blood cell units stored \>=21 days at time of transfusion. Can be AS1, AS3, or AS5. Frozen, deglycerolized, washed, and volume-reduced products are protocol violations.

Timeline

Start date
2010-01-01
Primary completion
2014-03-01
Completion
2014-03-01
First posted
2009-10-08
Last updated
2015-06-09
Results posted
2015-06-09

Locations

33 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00991341. Inclusion in this directory is not an endorsement.